Harbourvest Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Harbourvest Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-162,131	Closed	-$8.05M	–	34
2018 Q2	$8.05M	Buy	162,131 +46,399	+40%	+$2.25M	10.17%	5
2018 Q1	$5.65M	Sell	115,732 -4,655	-4%	-$242K	6.08%	5
2017 Q4	$5.07M	Hold	120,387	–	–	4.08%	4
2017 Q3	$5.16M	Buy	120,387 +76,242	+173%	+$2.43M	3.4%	5
2017 Q2	$578K	Sell	44,145 -51,374	-54%	-$677K	0.25%	15
2017 Q1	$1.26M	Buy	95,519 +51,374	+116%	+$658K	0.7%	9
2016 Q4	$572K	Buy	+44,145	New	+$680K	0.35%	12

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Harbourvest Partners's MYOK Position: Q3 2018 in Review

Harbourvest Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2018, closing a stake of 162,131 shares — an estimated $8.05M sold.

Harbourvest Partners first reported a position in MYOK in Q4 2016 and held it in 7 quarters. The position peaked at $8.05M in Q2 2018. 125 funds tracked by Wall St. Rank hold MYOK as of Q3 2018.

Harbourvest Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Harbourvest Partners sold 162,131 MyoKardia, Inc. Common Stock shares in Q3 2018, an estimated $8.05M.
Harbourvest Partners first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 7 quarters.
Harbourvest Partners's MyoKardia, Inc. Common Stock position peaked at $8.05M in Q2 2018.
125 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2018.

Based on Harbourvest Partners's 13F filing for Q3 2018, filed 14 Nov 2018.